Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,362,420
+$3,761,112 QoQ
Shares Held
98,162
+40.6% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#135
of 477 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,853,717 across 210 Biotechnology names. CYTK ranks #31 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in CYTK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,362,420 | 98,162 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,601,308 | 69,812 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,462,985 | 70,239 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,779,708 | 68,772 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,863,621 | 56,405 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,671,356 | 91,350 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,212,902 | 89,560 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,806,489 | 91,032 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,413,826 | 63,009 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,088,393 | 58,314 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $4,052,186 | 48,535 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,697,572 | 57,623 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,770,124 | 54,265 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,286,147 | 93,383 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,403,237 | 30,625 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,517,533 | 113,881 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,077,082 | 103,769 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,556,085 | 69,440 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,388,188 | 74,335 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,733,072 | 76,471 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $601,952 | 30,417 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $694,148 | 29,843 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $691,454 | 33,275 | Shares | Sole | 2021-02-08 | |
| 2020-06-30 | $502,653 | 21,326 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||